Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) EBT Margin: 2009-2025

Historic EBT Margin for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to 54.78%.

  • UNITED THERAPEUTICS's EBT Margin rose 289.00% to 54.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 69.88%, marking a year-over-year increase of 1771.00%. This contributed to the annual value of 53.49% for FY2024, which is 126.00% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported EBT Margin of 54.78% as of Q3 2025, which was up 7.13% from 51.14% recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year EBT Margin high stood at 66.83% for Q1 2022, and its period low was -5,018.99% during Q4 2024.
  • For the 3-year period, UNITED THERAPEUTICS's EBT Margin averaged around -407.25%, with its median value being 53.31% (2025).
  • In the last 5 years, UNITED THERAPEUTICS's EBT Margin skyrocketed by 5,826bps in 2022 and then tumbled by 506,704bps in 2024.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's EBT Margin stood at 33.84% in 2021, then spiked by 254bps to 36.38% in 2022, then skyrocketed by 1,168bps to 48.06% in 2023, then plummeted by 506,704bps to -5,018.99% in 2024, then skyrocketed by 289bps to 54.78% in 2025.
  • Its EBT Margin stands at 54.78% for Q3 2025, versus 51.14% for Q2 2025 and 53.31% for Q1 2025.